Deborah DeRyckere Department of Pediatrics University of Colorado Anschutz Medical Campus Biography Publications Institution JoVE Articles Deborah DeRyckere has not added a biography. If you are Deborah DeRyckere and would like to personalize this page please email our Author Liaison for assistance. Publications UNC569, a Novel Small Molecule Mer Inhibitor with Efficacy Against Acute Lymphoblastic Leukemia in Vitro and in Vivo Molecular Cancer Therapeutics. Aug, 2013 | Pubmed ID: 23997116 MerTK Inhibition in Tumor Leukocytes Decreases Tumor Growth and Metastasis The Journal of Clinical Investigation. Aug, 2013 | Pubmed ID: 23867499 Mer Receptor Tyrosine Kinase is a Therapeutic Target in Pre-B-cell Acute Lymphoblastic Leukemia Blood. Aug, 2013 | Pubmed ID: 23861246 Molecular Pathways: MERTK Signaling in Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2013 | Pubmed ID: 23833304 UNC1062, a New and Potent Mer Inhibitor European Journal of Medicinal Chemistry. Jul, 2013 | Pubmed ID: 23693152 MERTK Receptor Tyrosine Kinase is a Therapeutic Target in Melanoma The Journal of Clinical Investigation. May, 2013 | Pubmed ID: 23585477 Bioluminescence Imaging of Leukemia Cell Lines in Vitro and in Mouse Xenografts: Effects of Monoclonal and Polyclonal Cell Populations on Intensity and Kinetics of Photon Emission Journal of Hematology & Oncology. 2013 | Pubmed ID: 23343252 Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia ACS Medicinal Chemistry Letters. Feb, 2012 | Pubmed ID: 22662287 Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus PloS One. 2012 | Pubmed ID: 22363695 Vandetanib Mediates Anti-leukemia Activity by Multiple Mechanisms and Interacts Synergistically with DNA Damaging Agents Investigational New Drugs. Apr, 2012 | Pubmed ID: 21046425 Mer Receptor Tyrosine Kinase is a Novel Therapeutic Target in Pediatric B-cell Acute Lymphoblastic Leukemia Blood. Sep, 2009 | Pubmed ID: 19643988 E2F1 and E2F2 Are Differentially Required for Homeostasis-driven and Antigen-induced T Cell Proliferation in Vivo Journal of Immunology (Baltimore, Md. : 1950). Jul, 2005 | Pubmed ID: 16002659 Characterization of Transcriptional Regulation During Negative Selection in Vivo Journal of Immunology (Baltimore, Md. : 1950). Jul, 2003 | Pubmed ID: 12847248 Identification and Characterization of Transcription Factor Target Genes Using Gene-targeted Mice Methods (San Diego, Calif.). Jan, 2002 | Pubmed ID: 12054905 酪氨酸激酶抑制剂的临床前评价急性白血病的治疗 Sandra Christoph1,2, Alisa B. Lee-Sherick1, Susan Sather1, Deborah DeRyckere1, Douglas K. Graham1 1Department of Pediatrics, University of Colorado Anschutz Medical Campus, 2Department of Bone Marrow Transplantation, University Hospital of Essen JoVE 50720 Medicine
酪氨酸激酶抑制剂的临床前评价急性白血病的治疗 Sandra Christoph1,2, Alisa B. Lee-Sherick1, Susan Sather1, Deborah DeRyckere1, Douglas K. Graham1 1Department of Pediatrics, University of Colorado Anschutz Medical Campus, 2Department of Bone Marrow Transplantation, University Hospital of Essen JoVE 50720 Medicine